Literature DB >> 847786

Central nervous system angioendothelosis. A treatable multiple infarct dementia.

J L Reinglass, J Muller, S Wissman, H Wellman.   

Abstract

CNS neoplastic angioendothelosis is a treatable primary proliferative disorder of the endothelial cells of blood vessels characterized by a clinical neurological picture of multiple infarct dementia and an inordinate amount of local cerebral edema, so striking that it may simulate primary or metastatic central nervous system tumor. The malignant cells remain within the lumen of the vessels and rarely if ever metastasize or occur in peripheral blood. There is remarkable improvement in symptoms by treating with high dose steroids. Antimetabolites and irradiation are suggested means of additional treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 847786     DOI: 10.1161/01.str.8.2.218

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

Review 1.  Intravascular lymphomatosis (neoplastic angioendotheliosis) of the central nervous system: case report and literature review.

Authors:  D Smadja; J L Mas; C Fallet-Bianco; O Meyniard; D Sicard; J de Recondo; P Rondot
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Neoplastic angioendotheliosis of the central nervous system.

Authors:  N Sunohara; M Mukoyama; E Satoyoshi
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

Review 3.  Neoplastic angioendotheliosis: a case of subacute dementia with unusual cerebral CT appearances and a review of the literature.

Authors:  R S Knight; P Anslow; J M Theaker
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

4.  Malignant angioendotheliosis involving the nervous system: support for a lymphoid origin of the neoplastic cells.

Authors:  S E Daniel; P Rudge; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

5.  Intravascular lymphomatosis: a clinicopathological study of three cases.

Authors:  U Liszka; M Drlicek; P Hitzenberger; E Machacek; H Mayer; G Stockhammer; W Grisold
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.